- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07499180
A Study on Body Posture and Eye Movements During Screen Usage on Adults Aged 18 to 65 Wearing Various Types of Eyeglasses (POEM)
April 7, 2026 updated by: Essilor International
Etude Des Comportements Posturaux et Oculomoteurs Durant l'Utilisation d'Outils Digitaux
The goal of this clinical study is to evaluate how adults aged 18 to 65 move their bodies and eyes when they use screens, with various eyeglasses. The main questions it aims to answer are :
- How the behaviour between young and presbyopes is different while performing visual tasks on digital devices ?
- How the behaviour while performing visual tasks changes according to different types of eyeglasses ? Participants will be asked to take part in an eye exam and do simple visual tasks on digital devices.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chloé Moger
- Phone Number: +33(0)155964827
- Email: mogerc@essilor.fr
Study Contact Backup
- Name: Valérie Parmentier
- Phone Number: +33(0)155964912
- Email: PARMENTV@ESSILOR.fr
Study Locations
-
-
-
Paris, France, 75012
- Recruiting
- Essilor International
-
Contact:
- Chloé Moger
- Phone Number: +33(0)1 55 96 48 27
- Email: mogerc@essilor.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Distance refractive error (equivalent sphere) between -3D and +3D
- Astigmatism inferior or equal to 1D
- Anisometropia inferior or equal to 1.5D
- Addition (for presbyopes) between 0.75D and 2.75D
- Minimum corrected visual acuity : 8/10
- Stable binocular vision
Exclusion Criteria:
- Employee of Essilor, Luxottica, GrandVision and their subsidiaries
- Aphakia, pseudophakia or ocular surgery
- Reported systemic pathology that affects vision
- Medical treatment or taking medications that affect vision
- Severe ocular pathology declared, involving a loss of visual field as in glaucoma, a loss of acuity
- Reported neurological deficit, including a history of seizure or sensorimotor coordination disorders, vestibular or cerebellar pathology
- Binocular vision problems such as amblyopia, strabismus, or double vision
- Vertebral or cervical troubles
- Difficulty to move, vertigo, ocular migraine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Young Adults
Young adults will test single vision lenses
|
Participants will get an eye exam
Measurement of the body posture and eye movements behaviour of digital device users while performing simple visual tasks with various types of lenses
|
|
Experimental: Presbyopes between 51 and 65 wearing progressive lenses
Presbyopes between 51 and 65 will test single vision and progressive lenses
|
Participants will get an eye exam
Measurement of the body posture and eye movements behaviour of digital device users while performing simple visual tasks with various types of lenses
|
|
Experimental: Presbyopes between 43 and 50 not wearing progressive lenses
Presbyopes between 43 and 50 will test single vision and progressive lenses
|
Participants will get an eye exam
Measurement of the body posture and eye movements behaviour of digital device users while performing simple visual tasks with various types of lenses
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantification of Gaze Lowering using an eye-tracker device
Time Frame: From enrollment to 3 months after enrollment
|
Quantitative Assessment of eye movements in degree with an eye-tracker during visual tasks
|
From enrollment to 3 months after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantification of Head and body inclination with a motion capture system
Time Frame: From enrollment to 3 months after enrollment
|
Quantitative evaluation of postural behavior in degree with a motion capture system while performing visual tasks
|
From enrollment to 3 months after enrollment
|
|
Digital device usage distance using motion capture system
Time Frame: From enrollment to 3 months after enrollment
|
Quantitative assessment of digital devices' usage distance during visual tasks
|
From enrollment to 3 months after enrollment
|
|
Correlation between refraction profile and visual tasks' postural behavior
Time Frame: From enrollment to 3 months after enrollment
|
Statistical analysis of the association between participant's refraction characteristics and their visual tasks' behavioral patterns (Quantification of Gaze Lowering, Quantification of head and body inclination, Digital device usage distance)
|
From enrollment to 3 months after enrollment
|
|
Correlation between binocular vision profile and visual tasks' postural behavior
Time Frame: From enrollment to 3 months after enrollment
|
Statistical analysis of the association between participant's binocular vision characteristics and their visual tasks' behavioral patterns (Quantification of Gaze Lowering, Quantification of head and body inclination, Digital device usage distance)
|
From enrollment to 3 months after enrollment
|
|
Correlation between accommodation profile and visual tasks' postural behavior
Time Frame: From enrollment to 3 months after enrollment
|
Statistical analysis of the association between participant's accommodation characteristics and their visual tasks' behavioral patterns (Quantification of Gaze Lowering, Quantification of head and body inclination, Digital device usage distance)
|
From enrollment to 3 months after enrollment
|
|
Correlation between head-eye ratio profile and visual tasks' postural behavior
Time Frame: From enrollment to 3 months after enrollment
|
Statistical analysis of the association between the head-eye ratio (relative contribution of the head and the eye in a composite movement involving both of them) and the visual tasks' behavioral patterns (Quantification of Gaze Lowering, Quantification of head and body inclination, Digital device usage distance)
|
From enrollment to 3 months after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chloé Moger, Essilor International
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 7, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
March 16, 2026
First Submitted That Met QC Criteria
March 23, 2026
First Posted (Actual)
March 30, 2026
Study Record Updates
Last Update Posted (Actual)
April 13, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WS10482
- 2025-A02528-41 (Other Identifier: ANSM RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingHealthy Adult Participants | Non-smoking, Healthy Adults | Normal Weight AdultsSpain
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Balgrist University HospitalNot yet recruiting
-
University of PennsylvaniaNational Institute on Aging (NIA)Not yet recruiting
-
MinicircleRecruiting
Clinical Trials on Eye exam
-
University of Maryland, BaltimoreRecruitingGraft Versus Host Disease in Eye | Ocular Complications | Inflammatory Dry Eye DiseaseUnited States
-
Essilor InternationalNot yet recruiting
-
Saccadous, Inc.Barrow Neurological Institute; Dignity HealthCompletedParkinson Disease | Parkinsonian Disorders | Corticobasal Degeneration | Progressive Supranuclear Palsy | Huntington Disease | Essential Tremor | Parkinson's Disease and Parkinsonism | Vascular Parkinsonism | Parkinsonian Syndrome | Multiple System Atrophy, Parkinson VariantUnited States
-
Rutgers, The State University of New JerseyTerminatedUveitisUnited States
-
Mayo ClinicCompletedDiabetes MellitusUnited States
-
Johns Hopkins UniversityAllerganCompleted
-
Ministry of Health, ThailandCompletedDiabetic RetinopathyThailand
-
Johns Hopkins UniversityDompe U.S. IncTerminatedDry Eye | Neurotrophic Keratitis | Sjogren's SyndromeUnited States
-
Rebiscan, Inc.Kaiser Foundation Research InstituteCompletedStrabismus | AmblyopiaUnited States
-
M.D. Anderson Cancer CenterTerminatedRetinoblastomaUnited States